Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINT: Transfusion Strategies in Acute Myocardial Infarction
NCT02981407Phase 3Completed
- Sponsor
- Rutgers University
- Start
- Apr 2017
- Primary completion
- May 2023
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of red blood cells in anemia (2 arms), sponsored by Rutgers University. Primary endpoint: Composite of All-cause Mortality or Nonfatal Myocardial Reinfarction at 30 days. Started Apr 2017; status: completed.
02
Drugs
red blood cells
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02981407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981407.